Quick note.

My report The Trading For Income System normally sells for $29.97 on our website.

But if you use this link today, it's yours free.

It shows you a side of the market most investors have never tried — the side where you can get paid up front, the moment the trade is placed, instead of waiting and hoping you're right.

It's written in plain English. No complicated math. No staring at charts all day.

And I'll be straight with you inside about the risks, too.

I can't promise this link will still be free tomorrow. So if you've been curious, now's the time.

Click here to grab your free copy before it goes back to $29.97.

Good Trading,
Bill Poulos

p.s. Normally $29.97. Free today with this link.

Why Concentra’s Quiet Healthcare Business Keeps Winning

Authored by Peter Frank. Publication Date: 10/2/2026.

Most investors have never been to a Concentra (NYSE: CON) clinic, and that’s good news.

The Texas-based company treats workers injured on the job and conducts the drug tests, physicals and pre-employment screenings that employers need.

My public warning after 55 years of watching the markets (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit.

Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.

See Martin Weiss's full warning before this risk spreads further

It’s not glamorous, but Concentra is the largest occupational health provider in the country, and business has rarely looked better.

Since Select Medical spun it off in 2024, Concentra has become one of the better healthcare stories on Wall Street.

The company is growing, widening its margins, paying down debt and paying a dividend all at the same time. Wall Street sees more upside ahead and has given the stock a unanimous Buy rating.

The harder question is price. After a big run in the stock, investors weighing Concentra need to decide whether a steady, blue-collar healthcare business can continue to justify a much richer price tag.

Earnings Show Concentra’s Strength

The numbers show how Concentra is dominating. The company’s second-quarter report on Aug. 6 beat expectations across the board. Revenue rose 10% to $606 million, above analysts’ projections of $592 million. Adjusted earnings per share came in at 52 cents, well ahead of the 42 cents analysts expected.

The growth came from two simple levers: more patients and higher prices. Both daily patient visits and revenue per visit rose, while workers’ compensation visits, the heart of the business, grew as well.

Profits increased even faster than sales. Net income attributable to the company came in at $65.3 million, up 46.5% from a year earlier, and margins widened.

Cash flow is the real engine. Free cash flow nearly doubled in the quarter, and using it to pay down debt should lower the company’s borrowing costs. Management raised its full-year outlook again and now expects 2026 revenue of $2.325 billion to $2.375 billion.

Growth Extends Across the Business

The positive side of the story is simple. Concentra dominates a fragmented market and is using its size to acquire smaller rivals and open new centers.

Revenue grew at a double-digit pace last year, and the company has met or beaten its guidance in every quarter since its July 2024 IPO.

It is also returning cash to shareholders through a quarterly dividend of 25 cents. In August, it bought back 1 million shares from outgoing chairman Robert A. Ortenzio and related entities.

Growth initiatives continue as well. With 633 occupational health centers and 415 onsite health centers, Concentra recently acquired four more occupational health centers in Minnesota’s Twin Cities and opened new centers in Boise, Kansas City and Daytona Beach.

Credit markets have taken notice. S&P Global upgraded Concentra’s credit rating on Aug. 27, citing strong performance and lower leverage.

Wall Street Sees More Upside

Wall Street firmly supports the company’s direction. All eight analysts covering the stock rate it a Buy, with one assigning a Strong Buy.

With the stock already up roughly 75% this year, the 12-month consensus price target is $39.40, meaning analysts expect it to rise another 14% or so. The highest price target is currently $43 per share, while the lowest is $30.

Labor Market Could Weigh on Growth

Although business is strong, there are risks. The most important is that Concentra’s fortunes are tied to the blue-collar job market. Fewer workers on factory floors, in warehouses and on construction sites would mean fewer injuries to treat and fewer new hires to screen.

Management has credited a resilient labor market for strong visit growth, but that tailwind could fade quickly if the economy cools. Pricing growth is also expected to slow for the rest of the year.

Debt and Competition Add Risks

There are other reasons for caution as well. Concentra still carries a sizable debt load of $1.57 billion, and much of its pricing is determined by state workers’ compensation fee schedules that it does not control. The company faces competition from hospital systems, urgent care chains and physical therapy providers such as U.S. Physical Therapy (NYSE: USPH).

Concentra is also in the middle of a leadership transition. On Nov. 1, President and CFO Matt DiCanio will become CEO, while longtime chief executive Keith Newton will become executive chairman. Robert Ortenzio will step down as chairman but remain on the board. On Sept. 8, Concentra named Tanner Newton, its senior vice president of strategy and finance, as the next CFO.

Strong Execution Faces a Valuation Test

Concentra is executing well. The business is growing, margins are widening, debt is coming down and the management transition is orderly and planned from within. Wall Street sees more upside ahead.

But a new CEO and CFO taking over at the same time adds some execution risk. Investors also need to keep in mind that much of the good news is already reflected in a stock that has risen sharply this year.

The next test comes with third-quarter results, expected in early November, just as the new leadership team takes over.

The AI Boom’s Next Big Winners May Wear Hard Hats

Authored by Bridget Bennett. Publication Date: 10/7/2026.

The scarcest input in the AI buildout may not be a chip or a power contract. It may be a licensed electrician.

Rob Spivey, director of research at Altimetry, calls this group of stocks the blue-collar millionaire plays. As hyperscaler spending climbs, the companies that employ skilled tradespeople and supply the equipment they use could capture more of the AI payoff than the market is currently pricing in.

Why Skilled Trades Are Becoming the AI Bottleneck

My public warning after 55 years of watching the markets (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit.

Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.

See Martin Weiss's full warning before this risk spreads further

Spivey sees two education trends moving in opposite directions. The number of college-age Americans has peaked, and he argues that the wage premium for many degrees has shrunk just as tuition has reached record highs. Entry-level white-collar roles in fields such as computer science are also among the most exposed to AI.

Vocational training is heading in the other direction. Spivey points to roughly 50% enrollment growth since 2022 in programs for welders, electricians, HVAC technicians and plumbers.

Demand explains the shift. Microsoft (NASDAQ: MSFT) President Brad Smith wrote in 2025 that the United States may need half a million new electricians over the next decade. Spivey argues that estimate came before the latest jump in spending. He cites hyperscaler capital expenditures (CapEx) of about $800 billion this year, with forecasts of $1.1 trillion and then $1.2 trillion in the years ahead. At that pace, he believes the need could be closer to 1 million workers.

When something becomes scarce, it gets expensive. That is good news for tradespeople and for the companies that can recruit, train and retain them.

EMCOR Turns Workforce Investment Into Backlog Growth

EMCOR Group (NYSE: EME) handles the electrical and mechanical work inside complex projects, typically working under a general contractor. Spivey estimates that about half of its business is now tied to data centers, with the rest spread across high-tech manufacturing, industrial and health care projects.

The demand shows up clearly. Remaining performance obligations reached a record $17.14 billion at the end of June, up nearly 44% from a year earlier, with data center contracts serving as a major driver.

What stands out to Spivey is how management talks about the business. Workforce comes first on earnings calls. He notes that frontline headcount has grown from about 34,000 to 44,000 in recent years, supported by recruiting and apprenticeship programs. In his view, that labor pool is the moat. More trained workers mean more projects EMCOR can take on.

The market's biggest question is how durable demand will be once data centers are built. Spivey's answer centers on hyperscaler economics. He projects that their earnings could reach roughly $1 trillion annually by 2030 on his uniform accounting basis, which would allow today's spending to pay back quickly and give companies a reason to keep investing.

Dycom Rides Fiber, Broadband and Data Center Power

Dycom Industries (NYSE: DY) is the company telecom carriers call to lay fiber. Spivey sees three tailwinds: government-funded rural broadband, the need to replace aging fiber that cannot handle today's speeds, and the acquisition of Power Solutions, a roughly $1.95 billion deal that moved Dycom into electrical work for data centers in the Washington, D.C., region.

Dycom also is not exposed to product obsolescence in the way a manufacturer such as Corning (NYSE: GLW) can be. New technology still has to go into the ground.

The chart has been rough. Shares have pulled back sharply in recent months, and Spivey ties much of that decline to broader concern across AI infrastructure as local opposition to data centers becomes an election issue. Company results played a role, too: The stock fell after its latest quarterly report amid concerns about communications margins and a shift in the timing of wireless revenue.

Political pushback may change where data centers are built, not whether they are built. Spivey expects more projects in power-rich, land-rich areas such as Texas, which would mean longer fiber runs and more work for Dycom.

United Rentals Supplies the Equipment Behind the Buildout

Every trench, foundation and power line needs lifts, forklifts, backhoes and earth-moving equipment. United Rentals (NYSE: URI) rents all of it.

The company also creates blue-collar millionaires directly. It is an active acquirer of family-owned rental businesses, turning decades of hard work into a payout for the owners.

Spivey argues that the market is pricing United Rentals' earnings as roughly flat. His uniform accounting points to the 2012 acquisition of RSC Holdings, which brought in a higher-return specialty rental model. On his adjusted basis, return on assets climbed from about 6% to 7% to around 12%, an improvement that the reported figures obscured. That mix of specialty services and scale sets it apart from rivals such as Herc Holdings (NYSE: HRI).

The demand is not limited to AI, either. Reshoring has fueled steady construction of factories, warehouses and logistics hubs since the pandemic.

Weighing the Upside Against the Risk for AI Infrastructure Stocks

The upside is a multiyear spending cycle meeting a real labor shortage. Companies that have already built their workforces could have pricing power that competitors cannot easily match.

The risk is that sentiment around AI CapEx can shift quickly, while political or permitting delays could push out project timelines. Execution on acquisitions and margins still matters, as Dycom's recent quarter showed.

Stay focused on backlog and headcount—because in this buildout, skilled hands are what turn CapEx into revenue.

Altimetry has also been digging into SpaceX (NASDAQ: SPCX) as an AI company, and the public stocks are positioned around that story. Get Altimetry's special report on the SpaceX AI opportunity to see the names on the research team's radar.